Cardiovascular risk in uremic patients: darkness after AURORA.

Suppr

超能文献

作者信息

Robles N R, Macias J F

机构信息

University of Salamanca School of Medicine, Salamanca, Spain.

出版信息

Ren Fail. 2010 Jan;32(2):269-72. doi: 10.3109/08860221003602652.

DOI:10.3109/08860221003602652

PMID:20199190

Abstract

摘要

相似文献

Cardiovascular risk in uremic patients: darkness after AURORA.

Ren Fail. 2010 Jan;32(2):269-72. doi: 10.3109/08860221003602652.

Rosuvastatin in patients undergoing hemodialysis.

N Engl J Med. 2009 Jul 2;361(1):93; author reply 94-5.

Rosuvastatin in patients undergoing hemodialysis.

N Engl J Med. 2009 Jul 2;361(1):93-4; author reply 94-5.

Rosuvastatin in patients with elevated C-reactive protein.

N Engl J Med. 2009 Mar 5;360(10):1040; author reply 1041-2.

Rosuvastatin in patients undergoing hemodialysis.

N Engl J Med. 2009 Jul 2;361(1):93; author reply 94-5. doi: 10.1056/NEJMc090901.

Sunset for statins after AURORA?

N Engl J Med. 2009 Apr 2;360(14):1455-7. doi: 10.1056/NEJMe0901067. Epub 2009 Mar 30.

Public health. U.S. panel favors wider use of preventive drug treatment.

Science. 2010 Jan 8;327(5962):130-1. doi: 10.1126/science.327.5962.130.

Rosuvastatin in patients with elevated C-reactive protein.

N Engl J Med. 2009 Mar 5;360(10):1039-40; author reply 1041-2.

Low-risk older patients (50 years and older) with raised high-sensitivity CRP (hs-CRP) benefit from rosuvastatin therapy: the JUPITER study.

Cardiovasc J Afr. 2008 Nov-Dec;19(6):332-4, discussion 335.

Is Jupiter also a god of primary prevention?

Tex Heart Inst J. 2010;37(1):6-7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Cardiovascular risk in uremic patients: darkness after AURORA.

Ren Fail. 2010 Jan;32(2):269-72. doi: 10.3109/08860221003602652.

Rosuvastatin in patients undergoing hemodialysis.

N Engl J Med. 2009 Jul 2;361(1):93; author reply 94-5.

Rosuvastatin in patients undergoing hemodialysis.

N Engl J Med. 2009 Jul 2;361(1):93-4; author reply 94-5.

Rosuvastatin in patients with elevated C-reactive protein.

N Engl J Med. 2009 Mar 5;360(10):1040; author reply 1041-2.

Rosuvastatin in patients undergoing hemodialysis.

N Engl J Med. 2009 Jul 2;361(1):93; author reply 94-5. doi: 10.1056/NEJMc090901.

Sunset for statins after AURORA?

N Engl J Med. 2009 Apr 2;360(14):1455-7. doi: 10.1056/NEJMe0901067. Epub 2009 Mar 30.

Public health. U.S. panel favors wider use of preventive drug treatment.

Science. 2010 Jan 8;327(5962):130-1. doi: 10.1126/science.327.5962.130.

Rosuvastatin in patients with elevated C-reactive protein.

N Engl J Med. 2009 Mar 5;360(10):1039-40; author reply 1041-2.

Low-risk older patients (50 years and older) with raised high-sensitivity CRP (hs-CRP) benefit from rosuvastatin therapy: the JUPITER study.

Cardiovasc J Afr. 2008 Nov-Dec;19(6):332-4, discussion 335.

Is Jupiter also a god of primary prevention?

Tex Heart Inst J. 2010;37(1):6-7.